ADDvise Group’s interim report for the period July 1 – September 30, 2023 will be published on October 26, 2023 at 07:45 (CEST).
Investors, analysts and other stakeholders are invited to a webcast and conference call at 14:00 (CEST) / 08:00 AM (EST) the same day where CEO Rikard Akhtarzand and CFO Oliver Humlen will present the report.
If you wish to participate via webcast, please use the link below.
If you wish to participate via conference call, please register via the link below. After registration you will receive a phone number and conference ID to access the conference.
The report and a link to the webcast will be made available on:
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
Oliver Humlen, CFO
+46 709-16 26 97
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The Group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expanding the business - both geographically and product-wise. ADDvise Group's shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.